| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1084162
Max Phase: Preclinical
Molecular Formula: C34H46N4O4S2
Molecular Weight: 638.90
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccc2cc(C(=O)NC3(C(=O)N[C@@H](CCCN4CCN(S(=O)(=O)C(C)C)CC4)Cc4ccccc4)CCCC3)sc2c1
Standard InChI: InChI=1S/C34H46N4O4S2/c1-25(2)44(41,42)38-20-18-37(19-21-38)17-9-12-29(23-27-10-5-4-6-11-27)35-33(40)34(15-7-8-16-34)36-32(39)31-24-28-14-13-26(3)22-30(28)43-31/h4-6,10-11,13-14,22,24-25,29H,7-9,12,15-21,23H2,1-3H3,(H,35,40)(H,36,39)/t29-/m0/s1
Standard InChI Key: KKHPSWFQBSAOJR-LJAQVGFWSA-N
Associated Targets(Human)
Neurokinin 2 receptor 3341 Activities
Associated Targets(non-human)
Neurokinin 2 receptor 349 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cavia porcellus 23802 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 638.90 | Molecular Weight (Monoisotopic): 638.2960 | AlogP: 5.12 | #Rotatable Bonds: 12 |
| Polar Surface Area: 98.82 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: | CX Basic pKa: 6.72 | CX LogP: 5.36 | CX LogD: 5.28 |
| Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.29 | Np Likeness Score: -1.14 |
References
| 1. Fattori D, Porcelloni M, D'Andrea P, Catalioto RM, Ettorre A, Giuliani S, Marastoni E, Mauro S, Meini S, Rossi C, Altamura M, Maggi CA.. (2010) Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor., 53 (10): [PMID:20408549] [10.1021/jm100176s] |
Source
Source(1):